HK1001396A1 - Pyrimidinylpyrazole derivative - Google Patents

Pyrimidinylpyrazole derivative

Info

Publication number
HK1001396A1
HK1001396A1 HK98100241A HK98100241A HK1001396A1 HK 1001396 A1 HK1001396 A1 HK 1001396A1 HK 98100241 A HK98100241 A HK 98100241A HK 98100241 A HK98100241 A HK 98100241A HK 1001396 A1 HK1001396 A1 HK 1001396A1
Authority
HK
Hong Kong
Prior art keywords
group
hydrogen atom
chem
formula
pyrimidinylpyrazole
Prior art date
Application number
HK98100241A
Other languages
English (en)
Inventor
Akio Ejima
Masamichi Sugimori
Ikuo Mitsui
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of HK1001396A1 publication Critical patent/HK1001396A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
HK98100241A 1994-09-26 1998-01-12 Pyrimidinylpyrazole derivative HK1001396A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22942294 1994-09-26
JP13501095 1995-06-01
PCT/JP1995/001934 WO1996010024A1 (en) 1994-09-26 1995-09-25 Pyrimidinylpyrazole derivative

Publications (1)

Publication Number Publication Date
HK1001396A1 true HK1001396A1 (en) 1998-06-19

Family

ID=26468965

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100241A HK1001396A1 (en) 1994-09-26 1998-01-12 Pyrimidinylpyrazole derivative

Country Status (14)

Country Link
US (1) US5852019A (ru)
EP (1) EP0784055B1 (ru)
KR (1) KR100388568B1 (ru)
CN (1) CN1071754C (ru)
AT (1) ATE232528T1 (ru)
CA (1) CA2201110A1 (ru)
DE (2) DE69529619D1 (ru)
DK (1) DK0784055T3 (ru)
ES (1) ES2192584T3 (ru)
FI (1) FI971227A (ru)
HK (1) HK1001396A1 (ru)
NO (1) NO313196B1 (ru)
TW (1) TW312694B (ru)
WO (1) WO1996010024A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002101B1 (ru) * 1997-01-27 2001-12-24 Дайити Фармасьютикал Ко., Лтд. Производные пиразола
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
EP1103551A1 (en) * 1998-07-24 2001-05-30 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives and salts thereof
AU3078000A (en) * 1999-01-25 2000-08-07 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compounds and antitumor agents containing the same as the active ingredient
DE60217322T2 (de) * 2001-04-27 2007-10-04 Zenyaku Kogyo K.K. Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
WO2003011837A1 (en) * 2001-08-01 2003-02-13 Merck & Co., Inc. Tyrosine kinase inhibitors
CA2512243A1 (fr) * 2003-01-28 2004-09-16 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US20050130989A1 (en) * 2003-01-28 2005-06-16 Aventis Pharma S. A. N-arylheteroaromatic products compositions containing them and use thereof
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
DK1741714T3 (da) 2004-03-31 2013-04-15 Zenyaku Kogyo Kk Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens
PL1864665T3 (pl) 2005-03-11 2012-10-31 Zenyaku Kogyo Kk Środek immunosupresyjny obejmujący związek heterocykliczny jako składnik aktywny
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
CA2675511A1 (en) 2006-10-10 2008-04-17 Amgen Inc. N-aryl pyrazole compounds for use against diabetes
US10287269B2 (en) * 2015-03-26 2019-05-14 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as PDE2 inhibitors
DK3356345T3 (da) 2015-09-30 2024-02-12 Max Planck Gesellschaft Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS4842072A (ru) * 1971-09-29 1973-06-19
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
CN1166833A (zh) 1997-12-03
TW312694B (ru) 1997-08-11
NO971384D0 (no) 1997-03-24
DE69529619T4 (de) 2005-01-27
EP0784055A4 (en) 1998-01-07
NO971384L (no) 1997-05-23
KR970706275A (ko) 1997-11-03
DE69529619T2 (de) 2003-12-18
ES2192584T3 (es) 2003-10-16
EP0784055A1 (en) 1997-07-16
FI971227A (fi) 1997-05-23
ATE232528T1 (de) 2003-02-15
KR100388568B1 (ko) 2003-10-04
DE69529619D1 (en) 2003-03-20
DK0784055T3 (da) 2003-06-02
CA2201110A1 (en) 1996-04-04
EP0784055B1 (en) 2003-02-12
NO313196B1 (no) 2002-08-26
CN1071754C (zh) 2001-09-26
WO1996010024A1 (en) 1996-04-04
US5852019A (en) 1998-12-22
FI971227A0 (fi) 1997-03-24

Similar Documents

Publication Publication Date Title
BE2018C008I2 (ru)
EP0945452A4 (en) SUGAR COMPOSITIONS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, METHODS OF PREPARING SAME, AND GEL COMPOSITIONS
DE69529619D1 (en) Pyrimidinylpyrazolderivate
ES2164241T3 (es) Compuestos pentaciclicos.
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
ATE248814T1 (de) 16-ene-vitamin d derivate
EP0806413A4 (en) 2-SUBSTITUTED VITAMIN D3 DERIVATIVES
ES2157679T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
AU2639999A (en) Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives
DK0565059T3 (da) Indolderivat
ATE189813T1 (de) Prostaglandin-i-analoga

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060925